Top Markets
#1 QuantixAI QuantixAI +105.36%
#2 龙虾 (Lobster) 龙虾 (Lobster) +36.43%
#3 MetaDAO MetaDAO +28.82%
#4 Rain Rain +23.15%
#5 Pons Pons +19.66%
#6 Bedrock Bedrock +18.87%
#7 Prom Prom +18.28%
#8 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +17.63%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +17.19%
#10 Ontology Gas Ontology Gas +15.31%
Coin of the day
QuantixAI QuantixAI
設定
言語
日本
通貨
USD
テーマ
Metsera, Inc. Metsera, Inc.

Metsera, Inc.

MTSR
株式のランク #2738
Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in... Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in crafting both injectable and oral nutrient-stimulated hormone analog peptides. These therapeutic compounds are primarily aimed at addressing obesity, overweight conditions, and associated health issues. Its developmental pipeline features MET-097i and MET-233i, both under investigation for treating obesity and overweight patients. Furthermore, Metsera is advancing a potential combination therapy involving MET-233i and MET-097i. The company is also progressing additional drug candidates, including MET-002, MET-224o, MET-067i, and MET-034i, all of which target disorders such as diabetes and obesity. Founded in 2022, Metsera, Inc. maintains its corporate headquarters in New York, New York.
株価
$70.50
最終同期: 2025-11-14
時価総額
$7.33B
変化（1日）
0.00%
変化（1年）
116.32%
国
US
取引 Metsera, Inc. (MTSR)

カテゴリー

Healthcare
Metsera, Inc.（MTSR）のEPS
2026 時点のEPS TTM: 0
Metsera, Inc.の最新の財務報告と株価によると、同社の現在のEPS（TTM）は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Metsera, Inc.のEPS履歴（2026から2026まで）
各年末時点のEPS
年 EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS
企業 EPS EPSの差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH